Human neutralizing antibody against PUUV spike broadly protects rodent models against hantaviruses April 11, 2022
Emergex collaborates with nonprofit organization to advance yellow fever booster vaccine candidate April 7, 2022
Peptidomimetic TMPRSS2 inhibitor shows prophylactic and therapeutic activity against SARS-CoV-2 VOCs April 7, 2022
CARB-X option funding supports Clarametyx's development of anti-biofilm therapy CMTX-101 April 5, 2022
Aligos selects broad-spectrum coronavirus protease inhibitor ALG-097558 for advancement April 5, 2022